Kinder Morgan Derivative Gain (Loss) Excluded from Effectiveness increased by 2.7% to -$430.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.7%, from -$451.00M to -$430.00M. Over 4 years (FY 2021 to FY 2025), Derivative Gain (Loss) Excluded from Effectiveness shows a downward trend with a 4.8% CAGR.
abbv_derivative_gain_loss_excluded_from_effectiveness| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$377.00M | -$368.00M | -$370.00M | -$333.00M | -$355.00M | -$399.00M | -$426.00M | -$445.00M | -$443.00M | -$457.00M | -$452.00M | -$472.00M | -$464.00M | -$466.00M | -$442.00M | -$451.00M | -$452.00M | -$456.00M | -$442.00M | -$430.00M |
| QoQ Change | — | +2.4% | -0.5% | +10.0% | -6.6% | -12.4% | -6.8% | -4.5% | +0.4% | -3.2% | +1.1% | -4.4% | +1.7% | -0.4% | +5.2% | -2.0% | -0.2% | -0.9% | +3.1% | +2.7% |
| YoY Change | — | — | — | — | +5.8% | -8.4% | -15.1% | -33.6% | -24.8% | -14.5% | -6.1% | -6.1% | -4.7% | -2.0% | +2.2% | +4.4% | +2.6% | +2.1% | +0.0% | +4.7% |